News
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
The U.S. Food and Drug Administration on Friday approved Novavax's COVID-19 vaccine, but placed additional conditions on ...
The vaccine will only be available to those at high risk from Covid—excluding those who may need it to protect a relative or ...
FDA Commissioner Marty Makary said his agency plans to release a new framework for vaccine approvals in “coming days.” ...
The GOP-led House Judiciary Committee is requesting records from Pfizer’s CEO and an interview with a former company ...
With new testing requirements, it’s not even clear whether new Covid or flu shots can be made available this fall.
A former Pfizer scientist said the timing of the 2020 vaccine results “wasn’t a coincidence,” according to allegations ...
Misinformation is making it hard for Canada to reach the vaccination levels needed to prevent the spread of measles, experts ...
WASHINGTON (Reuters) -U.S. lawmakers on Thursday asked Pfizer Inc for information on alleged comments by a former executive ...
The Trump administration plans to drop routine COVID vaccination guidance for kids and pregnant women, marking a major shift ...
Adults over the age of 60 are recommended not to get the chikungunya vaccine to prevent the mosquito-borne illness due to two ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results